论文信息 - Imatinib in Philadelphia chromosome‐positive chronic phase CML patients: Molecular and cytogenetic response rates and prediction of clinical outcome - 字舞流文

Imatinib in Philadelphia chromosome‐positive chronic phase CML patients: Molecular and cytogenetic response rates and prediction of clinical outcome

D. Huhn | M. Schwarz | K. Kreuzer | C. Schmidt | H. Gschaidmeier | M. Holdhoff | G. Ehninger | U. Platzbecker | J. Lupberger | W. Prejzner | P. le Coutre | G. Baskaynak | Il-Kang Na